Copyright Reports & Markets. All rights reserved.

Global Infection Control in Cancer Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Infection Control in Cancer Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Radiation Therapy
      • 1.4.3 Immunotherapy
      • 1.4.4 Traditional Surgery
      • 1.4.5 Stem Cell Transplant Therapy
      • 1.4.6 Chemotherapy
      • 1.4.7 Targeted Therapy
      • 1.4.8 Photodynamic Therapy
      • 1.4.9 Other
    • 1.5 Market by Application
      • 1.5.1 Global Infection Control in Cancer Therapy Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Pharmaceutical Companies
      • 1.5.4 Medical device companies
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Infection Control in Cancer Therapy Market Size
    • 2.2 Infection Control in Cancer Therapy Growth Trends by Regions
      • 2.2.1 Infection Control in Cancer Therapy Market Size by Regions (2014-2025)
      • 2.2.2 Infection Control in Cancer Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Infection Control in Cancer Therapy Market Size by Manufacturers
      • 3.1.1 Global Infection Control in Cancer Therapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Infection Control in Cancer Therapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Infection Control in Cancer Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Infection Control in Cancer Therapy Key Players Head office and Area Served
    • 3.3 Key Players Infection Control in Cancer Therapy Product/Solution/Service
    • 3.4 Date of Enter into Infection Control in Cancer Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Infection Control in Cancer Therapy Market Size by Type (2014-2019)
    • 4.2 Global Infection Control in Cancer Therapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Infection Control in Cancer Therapy Market Size (2014-2019)
    • 5.2 Infection Control in Cancer Therapy Key Players in United States
    • 5.3 United States Infection Control in Cancer Therapy Market Size by Type
    • 5.4 United States Infection Control in Cancer Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Infection Control in Cancer Therapy Market Size (2014-2019)
    • 6.2 Infection Control in Cancer Therapy Key Players in Europe
    • 6.3 Europe Infection Control in Cancer Therapy Market Size by Type
    • 6.4 Europe Infection Control in Cancer Therapy Market Size by Application

    7 China

    • 7.1 China Infection Control in Cancer Therapy Market Size (2014-2019)
    • 7.2 Infection Control in Cancer Therapy Key Players in China
    • 7.3 China Infection Control in Cancer Therapy Market Size by Type
    • 7.4 China Infection Control in Cancer Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Infection Control in Cancer Therapy Market Size (2014-2019)
    • 8.2 Infection Control in Cancer Therapy Key Players in Japan
    • 8.3 Japan Infection Control in Cancer Therapy Market Size by Type
    • 8.4 Japan Infection Control in Cancer Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Infection Control in Cancer Therapy Market Size (2014-2019)
    • 9.2 Infection Control in Cancer Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Infection Control in Cancer Therapy Market Size by Type
    • 9.4 Southeast Asia Infection Control in Cancer Therapy Market Size by Application

    10 India

    • 10.1 India Infection Control in Cancer Therapy Market Size (2014-2019)
    • 10.2 Infection Control in Cancer Therapy Key Players in India
    • 10.3 India Infection Control in Cancer Therapy Market Size by Type
    • 10.4 India Infection Control in Cancer Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Infection Control in Cancer Therapy Market Size (2014-2019)
    • 11.2 Infection Control in Cancer Therapy Key Players in Central & South America
    • 11.3 Central & South America Infection Control in Cancer Therapy Market Size by Type
    • 11.4 Central & South America Infection Control in Cancer Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Kimberly Clark Corporation
      • 12.1.1 Kimberly Clark Corporation Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Infection Control in Cancer Therapy Introduction
      • 12.1.4 Kimberly Clark Corporation Revenue in Infection Control in Cancer Therapy Business (2014-2019)
      • 12.1.5 Kimberly Clark Corporation Recent Development
    • 12.2 3M Healthcare Company
      • 12.2.1 3M Healthcare Company Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Infection Control in Cancer Therapy Introduction
      • 12.2.4 3M Healthcare Company Revenue in Infection Control in Cancer Therapy Business (2014-2019)
      • 12.2.5 3M Healthcare Company Recent Development
    • 12.3 Honeywell International, Inc.
      • 12.3.1 Honeywell International, Inc. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Infection Control in Cancer Therapy Introduction
      • 12.3.4 Honeywell International, Inc. Revenue in Infection Control in Cancer Therapy Business (2014-2019)
      • 12.3.5 Honeywell International, Inc. Recent Development
    • 12.4 Getinge Group AB
      • 12.4.1 Getinge Group AB Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Infection Control in Cancer Therapy Introduction
      • 12.4.4 Getinge Group AB Revenue in Infection Control in Cancer Therapy Business (2014-2019)
      • 12.4.5 Getinge Group AB Recent Development
    • 12.5 Sterigenics International
      • 12.5.1 Sterigenics International Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Infection Control in Cancer Therapy Introduction
      • 12.5.4 Sterigenics International Revenue in Infection Control in Cancer Therapy Business (2014-2019)
      • 12.5.5 Sterigenics International Recent Development
    • 12.6 Sakura Global Holding Company
      • 12.6.1 Sakura Global Holding Company Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Infection Control in Cancer Therapy Introduction
      • 12.6.4 Sakura Global Holding Company Revenue in Infection Control in Cancer Therapy Business (2014-2019)
      • 12.6.5 Sakura Global Holding Company Recent Development
    • 12.7 Arizant Healthcare Inc.
      • 12.7.1 Arizant Healthcare Inc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Infection Control in Cancer Therapy Introduction
      • 12.7.4 Arizant Healthcare Inc. Revenue in Infection Control in Cancer Therapy Business (2014-2019)
      • 12.7.5 Arizant Healthcare Inc. Recent Development
    • 12.8 Nordion
      • 12.8.1 Nordion Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Infection Control in Cancer Therapy Introduction
      • 12.8.4 Nordion Revenue in Infection Control in Cancer Therapy Business (2014-2019)
      • 12.8.5 Nordion Recent Development
    • 12.9 Cisa S.P.A.
      • 12.9.1 Cisa S.P.A. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Infection Control in Cancer Therapy Introduction
      • 12.9.4 Cisa S.P.A. Revenue in Infection Control in Cancer Therapy Business (2014-2019)
      • 12.9.5 Cisa S.P.A. Recent Development
    • 12.10 Steris Corporation
      • 12.10.1 Steris Corporation Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Infection Control in Cancer Therapy Introduction
      • 12.10.4 Steris Corporation Revenue in Infection Control in Cancer Therapy Business (2014-2019)
      • 12.10.5 Steris Corporation Recent Development
    • 12.11 Nordion, Inc.
    • 12.12 Ahlstrom Filtration LLC
    • 12.13 Membrana GmbH
    • 12.14 Synergy Health, Plc
    • 12.15 Advanced Sterilization Products Services, Inc

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      The Preventing Infections in Cancer Patients campaign provides resources to help lower the risk of cancer patients developing potentially life-threatening infections during chemotherapy treatment.
      In 2018, the global Infection Control in Cancer Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Infection Control in Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infection Control in Cancer Therapy development in United States, Europe and China.

      The key players covered in this study
      Kimberly Clark Corporation
      3M Healthcare Company
      Honeywell International, Inc.
      Getinge Group AB
      Sterigenics International
      Sakura Global Holding Company
      Arizant Healthcare Inc.
      Nordion
      Cisa S.P.A.
      Steris Corporation
      Nordion, Inc.
      Ahlstrom Filtration LLC
      Membrana GmbH
      Synergy Health, Plc
      Advanced Sterilization Products Services, Inc

      Market segment by Type, the product can be split into
      Radiation Therapy
      Immunotherapy
      Traditional Surgery
      Stem Cell Transplant Therapy
      Chemotherapy
      Targeted Therapy
      Photodynamic Therapy
      Other

      Market segment by Application, split into
      Hospital
      Pharmaceutical Companies
      Medical device companies
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Infection Control in Cancer Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Infection Control in Cancer Therapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Infection Control in Cancer Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now